mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.8 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.8 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.8 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.006 |
0.8 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.8 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.0083 |
0.9 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |